Genmab A/s Earnings

Genmab A/s’s revenue fell -82.88% since last year same period to $925Mn in the Q2 2025. On a quarterly growth basis, Genmab A/s has generated -81.25% fall in its revenue since last 3-months.

Genmab A/s’s net profit fell -76.14% since last year same period to $336Mn in the Q2 2025. On a quarterly growth basis, Genmab A/s has generated 72.31% jump in its net profits since last 3-months.

Genmab A/s’s net profit margin jumped 39.36% since last year same period to 36.32% in the Q2 2025. On a quarterly growth basis, Genmab A/s has generated 818.85% jump in its net profit margins since last 3-months.

Genmab A/s’s price-to-earnings ratio after this Q2 2025 earnings stands at 13.01.

Genmab A/s’s earning per share (EPS) estimates for the current quarter stand at 0.44 - a 29.41% jump from last quarter’s estimates.

Genmab A/s’s earning per share (EPS) estimates for the current year stand at 0.44.

Genmab A/s’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Genmab A/s has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.